Obesity in COPD: Comorbidities with Practical Consequences?

References

• Franssen FME, O’Donnell DE, Goossens GH, Blaak EE, Schols AMWJ. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63(12):1110–7.
   PubMed Web of Science ®Google Scholar
• Koniski ML, Salhi H, Lahlou A, Rashid N, El Hasnaoui A. Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study. Int J Chron Obstruct Pulmon Dis. 2015;10(1):1685–94.
   PubMed Web of Science ®Google Scholar
• Liu Y, Pleasants RA, Croft JB, Lugigo N, Ohar J, Heidari K, et al. Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease. Respir Med. 2015;109(7):851–9.
   PubMed Web of Science ®Google Scholar
• Behrens G, Matthews CE, Moore SC, Hollenbeck AR, Leitzmann MF. Body size and physical activity in relation to incidence of chronic obstructive pulmonary disease. CMAJ. 2014;186(12):E457–69.
   PubMed Web of Science ®Google Scholar
• WHO. Obesity and Overweight Fact Sheet. Geneva (Switzerland): WHO; 2015.
   Google Scholar
• Brink CL van den (RIVM) BA (RIVM). How many people are overweight? Volksgezond Toekomst Verkenning, Natl Kompas Volksgezond Bilthoven RIVM, Dutch. 2016.
   Google Scholar
• From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. Gold Guid. 2016:1–94.
   Google Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23.
   PubMed Web of Science ®Google Scholar
• Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–32.
   PubMed Web of Science ®Google Scholar
• Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet (London, England). 2011;378(9793):815–25.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Blanc PD, Sidney S, Yelin ED, Lathon PV, Katz PP, Tolstykh I, Ackerson L, Iribarren C. Body composition and functional limitation in COPD. Respir Res. 2007;8:7.
   PubMed Web of Science ®Google Scholar
• Vozoris NT, O’Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J. 2012;19(3):e18–24.
   PubMed Web of Science ®Google Scholar
• Montes de Oca M, Tálamo C, Perez-Padilla R, et al. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Respir Med. 2008;102(5):642–50.
   PubMed Web of Science ®Google Scholar
• Steuten LMG, Creutzberg EC, Vrijhoef HJM, Wouters EF. COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J. 2006;15(2):84–91.
   PubMedGoogle Scholar
• Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest. 2002;122(4):1256–1263.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Deesomchok A, Lam YMM, Guenette JA, Amornputtisathaporn N, Forkert L, Webb KA. Effects of BMI on static lung volumes in patients with airway obstruction. Chest. 2011;140(2):461–468.
   PubMed Web of Science ®Google Scholar
• Vanfleteren LEGW, Spruit MA, Groenen M, Gaffron S, van Empel VPM, Bruijnzeel PLB, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–35.
   PubMed Web of Science ®Google Scholar
• Divo MJ, Casanova C, Marin JM, et al. COPD comorbidities network. Eur Respir J. 2015;46(3):640–50.
   PubMed Web of Science ®Google Scholar
• Cleutjens F, Triest F, Wilke S, Vanfleteren LEGW, Franssen FME, Janssen DJA, Rutten EP, Spruit MA, Wouters EF. New insights in chronic obstructive pulmonary disease and comorbidity. Am J Respir Crit Care Med. 2015;191(9):1081–2.
   PubMedGoogle Scholar
• Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, Stoller JK, Thomashow BM, Turino GM. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122(4):348–55.
   PubMed Web of Science ®Google Scholar
• Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–75.
   PubMedGoogle Scholar
• Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–62.
   PubMed Web of Science ®Google Scholar
• Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–9.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003;163(12):1475–80.
   PubMedGoogle Scholar
• Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991–1999. COPD. 2005;2(1):35–41.
   PubMedGoogle Scholar
• Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128(4):2099–107.
   PubMed Web of Science ®Google Scholar
• Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J, Poirier P. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005;25(4):226–32.
   PubMedGoogle Scholar
• Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128(4):2005–11.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993;6(Suppl 16):5–40.
   PubMed Web of Science ®Google Scholar
• ATS, ERS. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(5 Pt 2):S77–S121.
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
   PubMedGoogle Scholar
• Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–61.
   PubMed Web of Science ®Google Scholar
• Jones RCM, Dickson-Spillmann M, Mather MJC, Marks D, Shackell BS. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res. 2008;9:62.
   PubMed Web of Science ®Google Scholar
• Walters JA, Haydn Walters E, Nelson M, Robinson A, Scott J, Turner P, Wood-Baker R. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J. 2011;20(4):396–402.
   PubMedGoogle Scholar
• Short ME, Goetzel RZ, Pei X, Tabrizi MJ, Ozminkowski RJ, Gibson TB, Dejoy DM, Wilson MG. How accurate are self-reports? Analysis of self-reported health care utilization and absence when compared with administrative data. J Occup Environ Med. 2009;51(7):786–96.
   PubMed Web of Science ®Google Scholar
• Austin EJ, Deary IJ, Gibson GJ, McGregor MJ, Dent JB. Individual response spread in self-report scales: personality correlations and consequences. Pers Individ Dif. 1998;24(3):421–438.
   Web of Science ®Google Scholar
• Fan X. An exploratory study about inaccuracy and invalidity in Adolescent Self-Report Surveys. Field Methods. 2006;18(3):223–244.
   Web of Science ®Google Scholar
• Torén K, Olin A-C, Lindberg A, et al. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS). Int J Chron Obstruct Pulmon Dis. 2016;11:927–33.
   PubMed Web of Science ®Google Scholar
• Barros ARG de, Pires MB, Raposo NMF. Importance of slow vital capacity in the detection of airway obstruction. J Bras Pneumol. 2013;39(3):317–22.
   PubMed Web of Science ®Google Scholar
• Nathell L, Nathell M, Malmberg P, Larsson K. COPD diagnosis related to different guidelines and spirometry techniques. Respir Res. 2007;8:89.
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–61.
   PubMed Web of Science ®Google Scholar
• Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63–70.
   PubMed Web of Science ®Google Scholar
• Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10(12):2794–800.
   PubMed Web of Science ®Google Scholar
• Mihalache A, Fitting JW, Nicod LP. Chronic obstructive pulmonary disease and its links with cardiovascular risk factors. Rev Médicale Suisse. 2015;11(495):2151–2, 2154–6.
   PubMedGoogle Scholar
• Rossi FF, Pedone C, Antonelli Incalzi R. Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation. Recenti Prog Med. 2011;102(3):109–13.
   PubMedGoogle Scholar
• Alonso JLI. Chronic obstructive pulmonary disease and cardiovascular disease. Arch Bronconeumol. 2010;46 Suppl 3:18–22.
   PubMedGoogle Scholar
• Divo MJ, Cabrera C, Casanova C, et al. Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. Chronic Obstr Pulm Dis. 2014;1(2):229–238.
   PubMedGoogle Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370(9589):797–799.
   PubMed Web of Science ®Google Scholar
• Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–55.
   PubMedGoogle Scholar
• Ortega FB, Sui X, Lavie CJ, Blair SN. Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality? Mayo Clin Proc. 2016;91(4):443–55.
   PubMed Web of Science ®Google Scholar
• Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD J Chronic Obstr Pulm Dis. 2015;12(1):14–18.
   Web of Science ®Google Scholar